ReviewInternational journal of molecular sciences2022

Overview of MicroRNAs as Diagnostic and Prognostic Biomarkers for High-Incidence Cancers in 2021.

Chunyan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.